Who founded Sancilio?

Sancilio was founded by Frederick Sancilio.

Who are Sancilio's investors?

Sancilio's investors include Signet Healthcare Partners.

How much funding has Sancilio raised?

Sancilio has disclosed $22M raised across 2 rounds.

Where is Sancilio headquartered?

Sancilio is headquartered in Riviera Beach, US.

Sancilio

Riviera Beach, US · 1 known investors

Sancilio & Company provides guidance and regulatory support to early-stage biopharmaceutical entrepreneurs on compliance, manufacturing, and funding strategy. Through its subsidiary Clearway Global, the firm offers a network of FDA-regulated services including drug manufacturing, formulation development, clinical trials, and regulatory submissions.

Biotech

Founders & leadership

Frederick SancilioFounder

Daren GrahamExecutive

Andrew FolmerExecutive

Stephen PorterExecutive

Board

Dennis LangerBoard director

Patrick GrayBoard director

Alan DuntonBoard director

Roderick JacksonBoard director

Investors · 1

Signet Healthcare PartnersNew York · $10M – $50M

Reported raises · per SEC filings

Form D private placements

$22M disclosed across 2 rounds · 2012–2014

▶$20MraisedJul 2014 · 9 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

Roderick JacksonDirector
Dennis LangerDirector
C. Chad HarrellExecutive Officer
Ted StoverExecutive Officer
Alan DuntonDirector
Frederick SancilioExecutive Officer, Director
Martin ZeigerDirector
Patrick GrayDirector
Kelly PerkinsDirector
Thorsteinsson ThorsteinnExecutive Officer
Carla CoxExecutive Officer

Offering amount: $20M
Amount sold: $20M
Minimum investment: $1
Sales commissions: $1M
Placement agents: Noble Financial Capital Markets
First sale: May 2014
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$2MraisedMar 2012 · 2 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

Dennis LangerDirector
Daren GrahamExecutive Officer
Frederick SancilioExecutive Officer, Director
Andrew FolmerExecutive Officer
Patrick GrayDirector
Alan DuntonDirector
Stephen PorterExecutive Officer
Roderick JacksonDirector

Offering amount: $4M
Amount sold: $2M
Minimum investment: $1
Proceeds to insiders: $50K
First sale: Feb 2012
Incorporated: Corporation, Florida
Federal exemptions: 06

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Sancilio do?: Sancilio & Company provides guidance and regulatory support to early-stage biopharmaceutical entrepreneurs on compliance, manufacturing, and funding strategy. Through its subsidiary Clearway Global, the firm offers a network of FDA-regulated services including drug manufacturing, formulation development, clinical trials, and regulatory submissions.
Who founded Sancilio?: Sancilio was founded by Frederick Sancilio.
Who are Sancilio's investors?: Sancilio's investors include Signet Healthcare Partners.
How much funding has Sancilio raised?: Sancilio has disclosed $22M raised across 2 rounds.
Where is Sancilio headquartered?: Sancilio is headquartered in Riviera Beach, US.